IPDQ.F Stock Overview
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
ImpediMed Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.082 |
| 52 Week High | AU$0.15 |
| 52 Week Low | AU$0.045 |
| Beta | 2.93 |
| 1 Month Change | 63.00% |
| 3 Month Change | -9.44% |
| 1 Year Change | -25.91% |
| 3 Year Change | -22.01% |
| 5 Year Change | -57.22% |
| Change since IPO | -81.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| IPDQ.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 5.4% | -2.9% | -3.2% |
| 1Y | -25.9% | -3.7% | 19.3% |
Return vs Industry: IPDQ.F underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: IPDQ.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| IPDQ.F volatility | |
|---|---|
| IPDQ.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IPDQ.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine IPDQ.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 76 | Parmjot Bains | www.impedimed.com |
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics.
ImpediMed Limited Fundamentals Summary
| IPDQ.F fundamental statistics | |
|---|---|
| Market cap | US$120.75m |
| Earnings (TTM) | -US$12.51m |
| Revenue (TTM) | US$6.72m |
18.0x
P/S Ratio-9.7x
P/E RatioIs IPDQ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IPDQ.F income statement (TTM) | |
|---|---|
| Revenue | AU$10.47m |
| Cost of Revenue | AU$1.37m |
| Gross Profit | AU$9.11m |
| Other Expenses | AU$28.60m |
| Earnings | -AU$19.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | -0.0096 |
| Gross Margin | 86.95% |
| Net Profit Margin | -186.16% |
| Debt/Equity Ratio | 0% |
How did IPDQ.F perform over the long term?
See historical performance and comparison